At Endo, our vision is to help everyone we serve live their best life. To achieve that vision, every day our global team members are focused on the development and delivery of life-enhancing products. For over 50 years, physicians and hospital pharmacies have relied upon our products to improve the lives of patients. Consequently, we are opposed to the inappropriate use of any of our medicines for capital punishment. We work with our wholesale distribution partners and support controls intended to preclude purchases of our medicines for this inappropriate use.
OpGen Stock Gains On FDA Approval, Interim Q3 Sales
The FDA has granted 510(k) clearance to OpGen Inc’s (NASDAQ:OPGN) Acuitas AMR Gene Panel. The Company is finalizing preparations for its commercial…
